Standard Biotools (LAB) Assets Average (2011 - 2026)

Standard Biotools (LAB) has reported Assets Average for 16 consecutive years, with $633.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Assets Average rose 11.42% year-over-year to $633.2 million in Q2 2026; TTM through Jun 2026 was $633.2 million, a 11.42% increase from a year earlier, with the FY2025 full-year figure at $590.0 million, up 26.16% from the prior year.
• Assets Average was $633.2 million for Q2 2026 at Standard Biotools, up from $603.4 million in the prior quarter.
• Over five years, Assets Average peaked at $743.2 million in Q2 2024 and troughed at $273.6 million in Q1 2022.
• A 5-year average of $501.3 million and a median of $549.3 million in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average jumped 104.32% in 2024 and fell 23.54% in 2025, its largest moves.
• Over 5 years, Assets Average stood at $402.6 million in 2022, then declined by 17.74% to $331.2 million in 2023, then jumped by 95.35% to $646.9 million in 2024, then slipped by 14.41% to $553.7 million in 2025, then rose by 14.35% to $633.2 million in 2026.
• The last three Assets Average figures came in at $633.2 million (Q2 2026), $603.4 million (Q1 2026), and $553.7 million (Q4 2025), per Business Quant data.